Evidence map›Paper›PMID 27199974›Full record

ArticleFrontiers in microbiology2016

Identification of a Peptide Produced by Bifidobacterium longum CECT 7210 with Antirotaviral Activity.

Empar Chenoll, Beatriz Casinos, Esther Bataller, Javier Buesa, Daniel Ramón, Salvador Genovés, Joan Fábrega, Montserrat Rivero Urgell, José A Moreno Muñoz

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Impact of the Microbiota on Viral Infections.Annual review of virology · 2023
    Review
  4. International journal of molecular sciences · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Probiotic Combination ofFrontiers in microbiology · 2017
    Article
  11. Article
  12. Evaluation of the Probiotic StrainFrontiers in microbiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Empar ChenollDepartment of AgroFood Biotechnology, Biópolis S.L. Valencia, Spain.
Beatriz CasinosDepartment of AgroFood Biotechnology, Biópolis S.L. Valencia, Spain.
Esther BatallerDepartment of AgroFood Biotechnology, Biópolis S.L. Valencia, Spain.
Javier BuesaDepartment of Microbiology, School of Medicine, University of Valencia - Hospital Clínico Universitario Valencia, Spain.
Daniel RamónDepartment of AgroFood Biotechnology, Biópolis S.L. Valencia, Spain.
Salvador GenovésDepartment of AgroFood Biotechnology, Biópolis S.L. Valencia, Spain.
Joan FábregaLaboratorios Ordesa S.L. Barcelona, Spain.
Montserrat Rivero UrgellLaboratorios Ordesa S.L. Barcelona, Spain.
José A Moreno MuñozLaboratorios Ordesa S.L. Barcelona, Spain.
Biopolis (Spain) · ESOrdesa (Spain) · ESHospital Clínico Universitario de Valencia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rotavirus is one of the main causes of acute diarrhea and enteritis in infants. Currently, studies are underway to assess the use of probiotics to improve rotavirus vaccine protection. A previous work demonstrated that the probiotic strain Bifidobacterium longum subsp. infantis CECT 7210 is able to hinder rotavirus replication both in vitro and in vivo. The present study takes a systematic approach in order to identify the molecule directly involved in rotavirus inhibition. Supernatant protease digestions revealed both the proteinaceous nature of the active substance and the fact that the molecule responsible for inhibiting rotavirus replication is released to the supernatant. Following purification by cationic exchange chromatography, active fractions were obtained and the functional compound was identified as an 11-amino acid peptide (MHQPHQPLPPT, named 11-mer peptide) with a molecular mass of 1.282 KDa. The functionality of 11-mer was verified using the synthesized peptide in Wa, Ito, and VA70 rotavirus infections of both HT-29 and MA-104 cell lines. Finally, protease activity was detected in B. longum subsp. infantis CECT 7210 supernatant, which releases 11-mer peptide. A preliminary identification of the protease is also included in the study.

Indexed as

11-mer peptideB. longum subsp. infantis CECT 7210probioticsproteaserotavirus

Identifiers

PMID27199974
PMCPMC4855034
OpenAlexW2346679973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.